Predicting community acquired bloodstream infection in infants using full blood count parameters and C-reactive

Lieke Brouwer1,2, Robert Cunney3,4, Richard J Drew3,4,5

  • 1Public Health Laboratory, HSE, Cherry Orchard Hospital, Dublin, Ireland. lieke.brouwer@hse.ie.

PubMed

Insights

Machine learning models can identify infants unlikely to have bloodstream infections (BSI) using blood count and CRP tests. This can help avoid unnecessary antibiotic treatments while awaiting blood culture results.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Machine Learning
  • Biomarker Discovery

Background:

  • Bloodstream infections (BSI) in infants present with non-specific symptoms, complicating early diagnosis.
  • Blood culture results, the gold standard for BSI diagnosis, require up to 48 hours, often leading to empirical antibiotic use.
  • Accurate and timely identification of infants without BSI is crucial to prevent unnecessary antibiotic exposure and diagnostics.

Purpose of the Study:

  • To develop and evaluate predictive models for identifying infants unlikely to have BSI.
  • To utilize routinely available clinical data, specifically Full Blood Count (FBC) and C-reactive protein (CRP) levels.
  • To reduce the burden of unnecessary antibiotic treatments in infants with suspected BSI.

Main Methods:

  • Trained multiple machine learning models (logistic regression, LDA, kNN, SVM, random forest, decision tree) on data from 2693 infants (7-60 days old) with suspected BSI.
  • Utilized FBC and CRP values from infants treated between 2005 and 2022 at a tertiary pediatric hospital.
  • Validated the best performing models (decision tree, random forest) on the full dataset and a separate 2023 dataset.

Main Results:

  • All tested models demonstrated comparable sensitivities (47%-62%) and specificities (85%-95%).
  • Decision tree and random forest models effectively stratified infants into low- and high-risk groups for BSI.
  • Negative predictive values were high (> 99% for full dataset, > 97% for 2023 dataset), indicating high confidence in ruling out BSI in low-risk infants.

Conclusions:

  • Developed machine learning models capable of predicting negative blood cultures in infants aged 7-60 days with suspected BSI.
  • These models show potential to guide clinical decisions, reducing unnecessary antibiotic administration and diagnostic procedures.
  • Implementation of these models can improve antibiotic stewardship and patient outcomes in pediatric care.